Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 study evaluating pharmacodynamics, pharmacokinetics, safety and tolerability of VAY736 in idiopathic pulmonary fibrosis was termin…
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. [EARLY_Phase 1]
Early Phase 1 trial evaluating LOXL2 and TGFbeta1 signaling inhibition for idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 trial evaluating the impact of BI 1015550 taken for 12 weeks on lung function in idiopathic pulmonary fibrosis has completed with …
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Investigating Idiopathic Pulmonary Fibrosis in Greece
A completed clinical trial investigating idiopathic pulmonary fibrosis with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 open-label and crossover study investigating belumosudil for idiopathic pulmonary fibrosis has completed and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care [Phase 3]
Phase 3 trial of GLPG1690 in idiopathic pulmonary fibrosis was terminated.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care [Phase 3]
Phase 3 trial of GLPG1690 plus standard of care in idiopathic pulmonary fibrosis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
A terminated clinical trial evaluating self-monitoring of spirometry and symptoms via the patientMpower app in idiopathic pulmonary fibrosis…
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of AK3280 in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough [Phase 2]
Phase 2 trial evaluating NP-120 for idiopathic pulmonary fibrosis shows results on efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial update evaluating cyclophosphamide for acute exacerbation of idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial update for Cudetaxestat in idiopathic pulmonary fibrosis (IPF) evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]
Phase 1 pilot trial of herpesvirus treatment in idiopathic pulmonary fibrosis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 results update for a therapy intended to reduce autoantibodies in patients with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Treatment of IPF With Laparoscopic Anti-Reflux Surgery [NA]
A completed clinical trial evaluating laparoscopic anti-reflux surgery as a treatment approach in patients with idiopathic pulmonary fibrosi…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial evaluating GLPG1205 for Idiopathic Pulmonary Fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 4]
Phase 4 clinical trial evaluating pulmonary rehabilitation in idiopathic pulmonary fibrosis was terminated, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) [Phase 2]
Phase 2 study of Gefapixant (MK-7264) in idiopathic pulmonary fibrosis patients with persistent cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients [Phase 1, Phase 2]
The study reports completed Phase 1/Phase 2 results for TD139 versus placebo in idiopathic pulmonary fibrosis patients, with results posted …
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period [NA]
A completed clinical trial studying the disease behavior of idiopathic pulmonary fibrosis and interstitial lung disease during the peri-diag…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: CleanUP IPF for the Pulmonary Trials Cooperative [Phase 3]
Phase 3 trial of CleanUP IPF for Idiopathic Pulmonary Fibrosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: SD, IL-13 Production Rate in IPF [Phase 2]
Phase 2 trial update in idiopathic pulmonary fibrosis investigating SD and IL-13 production rate.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). [Phase 3]
Open-label Phase 3 trial assessing pirfenidone for idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial of BG00011 in idiopathic pulmonary fibrosis was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension [Phase 2]
A Phase 2 trial evaluating pirfenidone combined with sildenafil in advanced idiopathic pulmonary fibrosis with potential pulmonary hypertens…